Cargando…

Cardioprotective Effect of Paeonol on Chronic Heart Failure Induced by Doxorubicin via Regulating the miR-21-5p/S-Phase Kinase-Associated Protein 2 Axis

BACKGROUND: This study primarily explored the role of paeonol in doxorubicin (DOX)-induced chronic heart failure (CHF), considering the cardioprotective effect of paeonol on an epirubicin-induced cardiac injury. METHODS: DOX-induced CHF-modeled rats were treated with paeonol. Cardiac function and my...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Cong, Liu, Shuhong, Cao, Gaozhen, Hu, Yang, Wang, Run, Wu, Min, Liu, Mingya, Yiu, Kai Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294229/ https://www.ncbi.nlm.nih.gov/pubmed/35865382 http://dx.doi.org/10.3389/fcvm.2022.695004

Ejemplares similares

Habitual physical activity improves outcomes among patients with myocardial infarction
por: Cai, Sidong, et al.
Publicado: (2023)

Role of Cardiomyocyte-Derived Exosomal MicroRNA-146a-5p in Macrophage Polarization and Activation
por: Chen, Cong, et al.
Publicado: (2022)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Cardioprotective Effect of Paeonol and Danshensu Combination on Isoproterenol-Induced Myocardial Injury in Rats
por: Li, Hua, et al.
Publicado: (2012)

Paeonol Inhibits Cell Proliferation, Migration and Invasion and Induces Apoptosis in Hepatocellular Carcinoma by Regulating miR-21-5p/KLF6 Axis
por: Cai, Miaoguo, et al.
Publicado: (2020)

Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
por: Brennan, Sean, et al.
Publicado: (2022)

Assessment of left ventricular function and peripheral vascular arterial stiffness in patients with dipper and non-dipper hypertension
por: Chen, Yan, et al.
Publicado: (2018)

MicroRNA-194-5p Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis and Endoplasmic Reticulum Stress by Targeting P21-Activated Kinase 2
por: Fa, Hongge, et al.
Publicado: (2022)

Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure
por: Oh, Chang-Myung, et al.
Publicado: (2019)

Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure
por: Aali, Ehsan, et al.
Publicado: (2021)

Cardioprotective Roles of Endothelial Progenitor Cell-Derived Exosomes
por: Zeng, Cai-Yu, et al.
Publicado: (2021)

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022)

Endoplasmic Reticulum Stress–Induced Resistance to Doxorubicin Is Reversed by Paeonol Treatment in Human Hepatocellular Carcinoma Cells
por: Fan, Lulu, et al.
Publicado: (2013)

miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2021)

Periplocymarin Alleviates Doxorubicin-Induced Heart Failure and Excessive Accumulation of Ceramides
por: Yun, Weijing, et al.
Publicado: (2021)

Quercetin-induced cardioprotection against doxorubicin cytotoxicity
por: Chen, Jing-Yi, et al.
Publicado: (2013)

Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
por: Piegari, Elena, et al.
Publicado: (2020)

Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
por: Liu, Yihai, et al.
Publicado: (2021)

Corrigendum: miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2022)

Modulating Effect of Paeonol on Piglets With Ulcerative Colitis
por: Wang, Shanshan, et al.
Publicado: (2022)

Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection †
por: Kura, Branislav, et al.
Publicado: (2020)

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022)

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2013)

Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Argun, Mustafa, et al.
Publicado: (2016)

Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Tseng, Yi-Tang
Publicado: (2016)

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
por: Timm, Kerstin N., et al.
Publicado: (2020)

Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice
por: Azam, Mohammed Ali, et al.
Publicado: (2021)

Acrocomia aculeata associated with doxorubicin: cardioprotection and anticancer activity
por: Monteiro-Alfredo, Tamaeh, et al.
Publicado: (2023)

Paeonol inhibits the progression of intracerebral haemorrhage by mediating the HOTAIR/UPF1/ACSL4 axis
por: Jin, Zheng-Long, et al.
Publicado: (2021)

Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway
por: Wang, Shudong, et al.
Publicado: (2017)

Role of miR‐21‐5p/FilGAP axis in estradiol alleviating the progression of monocrotaline‐induced pulmonary hypertension
por: Hu, Xiaoyi, et al.
Publicado: (2022)

Paeonol enhances macrophage phagocytic function by modulating lipid metabolism through the P53-TREM2 axis
por: Miao, Jifei, et al.
Publicado: (2023)

Delivery of paeonol by nanoparticles enhances its in vitro and in vivo antitumor effects
por: Chen, Cong, et al.
Publicado: (2017)

Late-onset doxorubicin-induced congestive heart failure in an elderly cancer survivor: A case report
por: Suto, Hirotaka, et al.
Publicado: (2023)

Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase
por: Xue, Peipei, et al.
Publicado: (2017)

The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
por: Zilinyi, Rita, et al.
Publicado: (2018)

Paeonol attenuates heart failure induced by transverse aortic constriction via ERK1/2 signalling
por: Chen, Xu, et al.
Publicado: (2022)

Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario
por: Kleinbongard, Petra, et al.
Publicado: (2023)

Pharmacokinetics, Tissue Distribution and Excretion of Paeonol and Its Major Metabolites in Rats Provide a Further Insight Into Paeonol Effectiveness
por: Hu, Xintong, et al.
Publicado: (2020)

Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis
por: Chen, Cong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_asi0f3348m62uuhb2hfl9fjtse